Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Chemists laid off at GlaxoSmithKline
GlaxoSmithKline's June announcement that it was cutting 350 jobs worldwide is coming to fruition. The company just laid off 22 scientists at its Medicinal Chemistry and Oncology Department in Research Triangle Park, North Carolina.
Already this summer, the company laid off nearly 200 workers, with half in its research department in June and about 90 more from a manufacturing plant in Zebulon. Company spokespeople say its just part of GSK's overall R&D "restructuring" plan to increase research and development and make manufacturing more efficient.
- read more at the News & Observer
- see the Herald Sun story
Related Articles:
Big Pharma's biotech shift means layoffs for chemists
Ailing GlaxSmithKline to axe 350 R&D workers
GSK plant closure begins 5,000 job cuts
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
